Electra Therapeutics, Inc. ETRA
8.84 USD -0.27 (-2.96%)
Regular-session close
9.05 +0.21 +2.38%
After hours · Nov 13, 7:30 PM ET
7.62 Day range 9.37
7.31 52-week range 13.92
- YTD
- -33.28%
- 1 year
- -33.28%
News
benzinga.com Electra Therapeutics Q3 EPS $(3.47) Misses $(2.72) Estimate Electra Therapeutics (NASDAQ:ETRA) reported quarterly losses of $(3.47) per share which missed the analyst consensus estimate of $(2.72) by 27.57 percent. This is a 99.44 percent increase over losses…
globenewswire.com Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights Ipsoprubart Advancing in Global Registrational Program as Potential First Treatment for sHLH Broadly; Enrollment Completion Expected in Second Half of 2027 Ipsoprubart Therapeutic Expansion Underway…
defenseworld.net Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Orbimed Advisors Llc Buys 245,113 Shares Electra Therapeutics, Inc. (NASDAQ: ETRA - Get Free Report) Director Orbimed Advisors Llc purchased 245,113 shares of the firm's stock in a transaction on Tuesday, November 3rd. The stock was bought…
defenseworld.net Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Carl Gordon Purchases 245,113 Shares Electra Therapeutics, Inc. (NASDAQ: ETRA - Get Free Report) Director Carl Gordon acquired 245,113 shares of the company's stock in a transaction that occurred on Tuesday, November 3rd. The shares…
defenseworld.net Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Carl Gordon Purchases 245,113 Shares Electra Therapeutics, Inc. (NASDAQ: ETRA - Get Free Report) Director Carl Gordon acquired 245,113 shares of the company's stock in a transaction that occurred on Tuesday, November 3rd. The shares…
defenseworld.net Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Orbimed Advisors Llc Buys 245,113 Shares Electra Therapeutics, Inc. (NASDAQ: ETRA - Get Free Report) Director Orbimed Advisors Llc purchased 245,113 shares of the firm's stock in a transaction on Tuesday, November 3rd. The stock was bought…
benzinga.com This FirstEnergy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Analysts initiated coverage on FE, ACCV, XE and ETRA, issuing Buy, Outperform, Equal-Weight and Hold ratings with targets up to $50.- benzinga.com HC Wainwright & Co. Initiates Coverage On Electra Therapeutics with Buy Rating, Announces Price Target of $30 HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Buy rating and announces Price Target of $30.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 29.7% to $0.42 during Friday's pre-market session. The company's market cap stands at $63.6 million. Electra Therapeutics (NASDAQ:ETRA)…
benzinga.com Star Therapeutics Announces $200M Private Financing To Support Its Pipeline Of Potential Best-in-Disease Therapies The financing follows the July 2026 acquisition of Star subsidiary Vega Therapeutics and was co-led by OrbiMed and Janus Henderson Investors, with participation from Agent Capital, Catalio Capital…- benzinga.com JP Morgan Initiates Coverage On Electra Therapeutics with Overweight Rating, Announces Price Target of $36 JP Morgan analyst Anupam Rama initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating and announces Price Target of $36.
benzinga.com Jefferies Initiates Coverage On Electra Therapeutics with Buy Rating, Announces Price Target of $32 Jefferies analyst Akash Tewari initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Buy rating and announces Price Target of $32.
benzinga.com Evercore ISI Group Initiates Coverage On Electra Therapeutics with Outperform Rating, Announces Price Target of $36 Evercore ISI Group initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Outperform rating and announces Price Target of $36.
benzinga.com This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).
benzinga.com Cantor Fitzgerald Initiates Coverage On Electra Therapeutics with Overweight Rating Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 106.0% to $0.15 during Wednesday's pre-market session. Connect Biopharma Hldgs (NASDAQ:CNTB) stock increased by 79.43% to $1.78. The…